695 related articles for article (PubMed ID: 18640473)
1. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
3. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
4. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
Schwimmer JB; Deutsch R; Rauch JB; Behling C; Newbury R; Lavine JE
J Pediatr; 2003 Oct; 143(4):500-5. PubMed ID: 14571229
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
[TBL] [Abstract][Full Text] [Related]
7. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.
Schwimmer JB; Middleton MS; Deutsch R; Lavine JE
Aliment Pharmacol Ther; 2005 Apr; 21(7):871-9. PubMed ID: 15801922
[TBL] [Abstract][Full Text] [Related]
8. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease.
Nobili V; Manco M; Devito R; Ciampalini P; Piemonte F; Marcellini M
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1553-61. PubMed ID: 17206944
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognosis of nonalcoholic fatty liver disease: is pharmacological therapy actually necessary?
Cinar K; Coban S; Idilman R; Tuzun A; Sarioglu M; Bektas M; Erden E; Bozkaya H; Ozden A
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):169-73. PubMed ID: 16706829
[TBL] [Abstract][Full Text] [Related]
10. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial.
Nair S; Diehl AM; Wiseman M; Farr GH; Perrillo RP
Aliment Pharmacol Ther; 2004 Jul; 20(1):23-8. PubMed ID: 15225167
[TBL] [Abstract][Full Text] [Related]
11. [Study on therapeutic effects of metformin on rat fatty livers induced by high fat feeding].
Gao ZQ; Lu FE; Dong H; Xu LJ; Wang KF; Zhou X
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):101-4. PubMed ID: 15727694
[TBL] [Abstract][Full Text] [Related]
12. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance.
de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R; Gonzalez JM
Diabetes Res Clin Pract; 2008 Jan; 79(1):74-8. PubMed ID: 17766001
[TBL] [Abstract][Full Text] [Related]
13. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
14. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.
Nobili V; Marcellini M; Devito R; Ciampalini P; Piemonte F; Comparcola D; Sartorelli MR; Angulo P
Hepatology; 2006 Aug; 44(2):458-65. PubMed ID: 16871574
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease.
Vilar Gomez E; Rodriguez De Miranda A; Gra Oramas B; Arus Soler E; Llanio Navarro R; Calzadilla Bertot L; Yasells Garcia A; Del Rosario Abreu Vazquez M
Aliment Pharmacol Ther; 2009 Nov; 30(10):999-1009. PubMed ID: 19691668
[TBL] [Abstract][Full Text] [Related]
16. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
[TBL] [Abstract][Full Text] [Related]
17. The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease.
Chou SC; Chen KW; Hwang JS; Lu WT; Chu YY; Lin JD; Chang HJ; See LC
Altern Ther Health Med; 2006; 12(3):34-9. PubMed ID: 16708768
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease in the pediatric population.
Lavine JE; Schwimmer JB
Clin Liver Dis; 2004 Aug; 8(3):549-58, viii-ix. PubMed ID: 15331063
[TBL] [Abstract][Full Text] [Related]
19. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
20. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
Nobili V; Manco M; Devito R; Di Ciommo V; Comparcola D; Sartorelli MR; Piemonte F; Marcellini M; Angulo P
Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
